Cancer in older men: A gender-based review

Aging Male

Volumn 9, Issue 3, 2006, Pages 149-158

  Cepeda, Oscar A ^a   Gammack, Julie K ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Chemotherapy; Elderly; Functional status; Life expectancy; Malignancy; Palliative care

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; GEMCITABINE; NAVELBINE; PREDNISONE; VINCRISTINE;

AGED; CANCER; CANCER EPIDEMIOLOGY; CANCER PALLIATIVE THERAPY; CANCER STAGING; CARCINOGENESIS; COLON CANCER; COMORBIDITY; ENVIRONMENTAL FACTOR; FUNCTIONAL STATUS; GENETIC RISK; HEMATOLOGIC MALIGNANCY; HUMAN; LIFE EXPECTANCY; LIFESTYLE; LUNG CANCER; MALE; PANCREAS CANCER; PATIENT ATTITUDE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; REVIEW;

AGE FACTORS; AGED; AGED, 80 AND OVER; HUMANS; MALE; NEOPLASMS; PREVALENCE; RISK FACTORS; SEX FACTORS; WORLD HEALTH;

EID: 33749501669     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.1080/13685530600804091     Document Type: Review

References (60)

1. Balducci L. New paradigms for treatment of elderly patients with cancer: The comprehensive geriatric assessment and guidelines for supportive care. J Support Oncol Nov/Dec 2003;1(4 Suppl 2):30-37.
2. Ershler W. Cancer: A disease of the elderly. J Support Oncol. Nov/Dec 2003;1(Suppl 2):5-10.
3. Yancick R, Ries LA. Aging and cancer in America: Demographic and epidemiologic perspectives. Hematol Oncol Clin North Am 2000;(14):17-23.
4. Suzman RM, Willis DP. The oldest old, New York, NY Oxford University Press; 1992.
5. Butler RN. Population aging and health. BMJ 1997;315:1082-1084.
6. Audisio RA, Repetta L, Zagonel V. Cancer in the elderly. In: Pollock RE, Doroshow JH, eds. UICC manual of clinical oncology, 8th edition. New Jersey: Wiley-Liss, 2004.
7. Yancick R, Ries LA. Cancer in older persons. Cancer 1994;74:1995-2003.
8. Smith DWE. Circulatory disease mortality in the elderly. Epidemiology 1997;8:501-504.
9. Hansen J. Common cancers in the elderly. Drugs and Aging 1998;13(6):467-478.
10. Hajjar RR. Cancer in the elderly: is it preventable? Clin Geriatr Med 2004;20(3):553-564.
11. Mesut R, Waldert M. Protstate cancer in the aging male. Int J Men's Health & Gender 1;1:47-54.
12. Trimble EL, Christian MC. Cancer treatment and the older patient. Clin Cancer Res. 2006;12(7 Pt 1):1956-1957.
13. Ershler WB. The influence of advanced age on cancer occurrence and growth. Cancer Treat Res 2005;124:75-87.
14. Ames BN, Shigenaga NK. Oxidants, antioxidants, and the degenerative diseases of Aging. Proc Natl Acad Sci USA 1993;90:7915-7922.
15. Balducci L, Yates J. General guidelines for management of older patients with cancer. Oncology 2000;14:221-227.
16. Lachs MS, Feinstein AR, Cooney LM Jr, Drickamer MA, Marottoli RA, Pannill FC, Tinetti ME. A simple procedure for general screening for functional disability in elderly patients. Ann Int Med 1990;112:699-706.
17. Harvey HA. The management of hypercalcemia of malignancy. Support Care Cancer. 1995;3(2):123-129.
18. Salive ME, Cornoni-Huntley J, Guralnik JM, Phillips CL, Wallace RB, Ostfeld AM, Cohen HJ. Anemia and hemoglobin levels in older persons relationship with age, gender and health status. J Am Geriatr Soc 1992;40(5):489-496.
19. Chaves PH, Ashar B, Guralnik JM, Fried LP. Looking at the relationship beetween hemoglobin concentration and previous mobility difficulty in older women: should the criteria used to define anemia in older people be changed? J Am Geriatr Soc 2002;50:1257-1264.
20. Morley J, Haddad R. Cancer as we age. Aging successfully 2002;12(3):1-8.
21. Wingo PA, Ries LA, Rosenberg HM, Miller DS, Edwards BK. Cancer incidence and mortality, 1973-1995: a report card for the U.S. Cancer Mar 1998;82(6):1197-1207.
22. Centers for Disease Control and Prevention (CDC). Trends in aging - United States and worldwide. MMWR Morb Mortal Wkly Rep 2003;52(6):101-104, 106.
23. Smith CV, Bauer JJ. Prostate cancer in men age 50 years or younger: A review of the department of defense Center for Prostate Disease Research Multicenter Cancer Database. J Urol 2000;164:1964-1967.
24. National Cancer Institute. Histologic grade and stage in Prostate Cancer Trends, 1973-1995, Accessed July 7, 2006. http://www.seer.cancer.gov// publications/prostate/grade.html.
25. Newcomer LM, Stanford JL, Blumenstein BA, Brawer MK. Temporal trends in rates of prostate cancer: Declining incidence of advanced stage disease 1974 to 1994. J Urol 1997;158:1127-1130.
26. Quin M, Babb P. Patterns and trends in prostate cancer incidence, survival prevalence, and mortality. BJU Int 2002;90:162-173.
27. Gronberg H. Prostate cancer epidemiology. Lancet 2003;361:859-864.
28. Lunfeld B. The ageing male: Demographics and challenges. World J Urol 2002;20:11-16.
29. Paquette EL, Sun L, Paquette LR, Connelly R, Mcleod DG, Moul JW. Improved prostate cancer-specific survival and other disease parameters: Impact of prostate-antigen testing. Urology 2002;60:756-759.
30. Ruchlin HS, Pellissier JM. An economic overview of prostate carcinoma. Cancer 2001;92:2796-2810.
31. Aus G, Abbou CC, Pacik D, Schmid HP, van Poppel H, Wolff JM, Zattoni F; EAU Working Group on Oncological Urology. EAU guidelines on prostate cancer. Eur Ural 2001;40:97-101.
32. Scherr D, Swindle PW, Scardino PT; National Comprehensive Cancer Network. Comprehensive cancer network guidelines for the management of prostate cancer. Urology 2003;61(2 Suppl):14-24.
33. Fowler Jr FJ, Mcnaughton Collins M, Albensen PC. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. J Am Med Assoc 2000;238:3217-3222.
34. Havlik RJ, Yancik R, Long S, Ries L, Edwards B. The National Cancer Institute on Aging and The National Cancer Institute SEER. Collaborative study on comorbidity and early diagnosis of cancer in the elderly. Cancer 1994;74:2101.
35. Balducci L, Beghe C. Cancer screening in the older person. Clin Geriatr Med 2002;18:505-528.
36. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111(6):1710-1717.
37. Carney DN. Carboplatin/etoposide combination chemotherapy in the treatment of poor prognosis patients with small cell lung cancer. Lung Cancer 1995;12(Suppl 3):S77-S83.
38. Janssen-Heijnen ML, Voebergh JW. Trends in incidence and prognosis of the histological sub-types of lung cancer in North America, Australia, New Zealand and Europe. Lung cancer 2001;31:123-137.
39. Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR. Lung cancer screening: The Mayo Program. J Occup Med 1986;28:746-750.
40. Melamed MR, Flehinger BJ, Zaman MB, Heelan RT, Perchick WA, Martini N. Screening for early lung cancer. Results of the memorial Sloan-Kettering study in New York. Chest 1984;86:44-53.
41. Goodwin JS, Samet JM, Key CR. Stage at diagnosis of cancer varies with age of the patient. J Am Geriatr Soc 1986;34:20-26.
42. National Center for Health Statistics. NVSR Volume 51, Number 3. (PHS) 2003-1120. Feb 8, 2005. United States Life Tables, 2000. Accessed July 7, 2006. http://www.cdc.gov/nchs/products/pubs/pubd/nvsr/51/51_03.htm.
43. Pagni S, McKelvey A, Riordan C, Federico JA, Ponn RB. Pulmonary resection for lung cancer in octogenarians. Ann Thorac Surg 1997;63:785-789.
44. Yamamoto K, Padilla Alarcon J, Calvo Medina V, Garcia-Zarza A, Pastor Guillen J, Blasco Armengod E, Paris Romeu F. Surgical results of stage I non-small cell lung cancer: Comparison between elderly and younger patients. Eur J Cardiothorac Surg 2003;23:21-25.
45. Gridelli C, Sheperd F. Chemotherapy for Elderly patients with non-small cell lung cancer. Chest 2005;128(2):947-957.
46. Grobovsky L, Kaplon M, Karnard AB. Feature of cancer in frail elderly patients. Proc Am Soc Clin Oncol 2000;19:2469.
47. National Cancer Institute. Surveillance epidemiology and end results. Fast stats: Colon and rectum cancer, Accessed on July 6, 2006. Available at: http://seer.cancer.gov/faststats/sites. php?site= Colon+and+Rectum+Cancer&stat=Mortality.
48. National Cancer Institute. Surveillance epidemiology and end results. Cancer stat fact sheets. Cancer of the colon and rectum. Accessed on July 6, 2006. Available at: http://seer.cancer.gov/statfacts/html/colorect.html.
49. Walsh J, Terdiman J. Colorectal cancer screening. JAMA 2003;289:1288-1296.
50. Arveux I, Boutron MC, El Mrini T, Arveux P, Liabeuf A, Pfitzenmeyer P, Faivre J. Colon cancer in the elderly: evidence for major improvements in health care and survival. Br J Cancer 1997;76(7):963-967.
51. Honecker F, Kohne CH, Bokemeyer C. Colorectal cancer in the elderly: is palliative chemotherapy of value? Drugs Aging 2003;20(1):1-11.
52. Stein BN, Petrelli NJ, Douglass HO, Driscoll DL, Arcangeli G, Meropol NJ. Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trial. Cancer Jan 1995;75(1):11-17.
53. Murr MM, Sarr MG, Oishi AJ, van Heerden JA. Pancreatic cancer. CA Cancer J Clin Sep/Oct 1994;44(5):304-318.
54. Schmiegel W. Tumor markers in pancreatic cancer - current concepts. Hepatogastroenterology 1989;36(6):446-449.
55. Bathe OF, Caldera H, Hamilton KL et al. Diminished benefit from resection of cancer of the head of the pancreas in patients of advanced age. Journal of Surgical Oncology-Supplement 2001;77:115-122.
56. Boring CC, Squires TS, Tong T. Cancer statistics, 1994. CA Cancer J Clin 1994;44:7-26.
57. Zagonel V, Monfardini S, Tirelli U, Carbone A, Pinto A. Management of hematologic malignancies in the elderly: 15-year experience at the Aviano Cancer Center, Italy. Crit Rev Oncol Hematol Sep 2001;39(3):289-305.
58. Tirelli U, Zagonel V, Errante D, Fratino L, Monfardini S. Treatment of non-Hodgkin's lymphoma in the elderly: an update. Hematol Oncol 1998;16(1):1-13.
59. Balducci L, Lyman GH. Patients aged > or = 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy. J Clin Oncol 2001;19(5):1583-1585.
60. Pinto A, Zagonel V, Ferrara F. Acute myeloid leukemia in the elderly: biology and therapeutic strategies. Crit Rev Oncol Hematol 2001;39(3):275-287.